These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

360 related articles for article (PubMed ID: 26830881)

  • 1. Long-Term Pharmacological Treatments of Anxiety Disorders: An Updated Systematic Review.
    Perna G; Alciati A; Riva A; Micieli W; Caldirola D
    Curr Psychiatry Rep; 2016 Mar; 18(3):23. PubMed ID: 26830881
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New approaches to the pharmacological management of generalized anxiety disorder.
    Buoli M; Caldiroli A; Caletti E; Paoli RA; Altamura AC
    Expert Opin Pharmacother; 2013 Feb; 14(2):175-84. PubMed ID: 23282069
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Agomelatine for the treatment of generalized anxiety disorder.
    Buoli M; Grassi S; Serati M; Altamura AC
    Expert Opin Pharmacother; 2017 Sep; 18(13):1373-1379. PubMed ID: 28730851
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of drug treatments for generalised anxiety disorder: systematic review and meta-analysis.
    Baldwin D; Woods R; Lawson R; Taylor D
    BMJ; 2011 Mar; 342():d1199. PubMed ID: 21398351
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Treatment of generalized anxiety: new pharmacologic approaches].
    Boulenger JP
    Encephale; 1995; 21(6):459-66. PubMed ID: 8674471
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term treatment of anxiety disorders with pregabalin: a 1 year open-label study of safety and tolerability.
    Montgomery S; Emir B; Haswell H; Prieto R
    Curr Med Res Opin; 2013 Oct; 29(10):1223-30. PubMed ID: 23808960
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evidence-based pharmacotherapy of Generalized Anxiety Disorder.
    Baldwin DS; Polkinghorn C
    Int J Neuropsychopharmacol; 2005 Jun; 8(2):293-302. PubMed ID: 15576000
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vortioxetine, a multimodal antidepressant for generalized anxiety disorder: a systematic review and meta-analysis.
    Pae CU; Wang SM; Han C; Lee SJ; Patkar AA; Masand PS; Serretti A
    J Psychiatr Res; 2015 May; 64():88-98. PubMed ID: 25851751
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Current treatments of the anxiety disorders in adults.
    Ballenger JC
    Biol Psychiatry; 1999 Dec; 46(11):1579-94. PubMed ID: 10599485
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacologic treatments effective in both generalized anxiety disorder and major depressive disorder: clinical and theoretical implications.
    Casacalenda N; Boulenger JP
    Can J Psychiatry; 1998 Sep; 43(7):722-30. PubMed ID: 9773222
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pregabalin for the treatment of generalized anxiety disorder.
    Wensel TM; Powe KW; Cates ME
    Ann Pharmacother; 2012 Mar; 46(3):424-9. PubMed ID: 22395254
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacological Treatment of Generalised Anxiety Disorder: Current Practice and Future Directions.
    Fagan HA; Baldwin DS
    Expert Rev Neurother; 2023 Jun; 23(6):535-548. PubMed ID: 37183813
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pregabalin for the treatment of generalized anxiety disorder: a novel pharmacologic intervention.
    Bandelow B; Wedekind D; Leon T
    Expert Rev Neurother; 2007 Jul; 7(7):769-81. PubMed ID: 17610384
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pregabalin for generalized anxiety disorder: an updated systematic review and meta-analysis.
    Generoso MB; Trevizol AP; Kasper S; Cho HJ; Cordeiro Q; Shiozawa P
    Int Clin Psychopharmacol; 2017 Jan; 32(1):49-55. PubMed ID: 27643884
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Generalized anxiety disorder. Longitudinal course and pharmacologic treatment.
    Schweizer E
    Psychiatr Clin North Am; 1995 Dec; 18(4):843-57. PubMed ID: 8748384
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacotherapy of generalized anxiety disorder.
    Davidson JR
    J Clin Psychiatry; 2001; 62 Suppl 11():46-50; discussion 51-2. PubMed ID: 11414551
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and safety of treatments for refractory generalized anxiety disorder: a systematic review.
    Samuel M; Zimovetz EA; Gabriel Z; Beard SM
    Int Clin Psychopharmacol; 2011 Mar; 26(2):63-8. PubMed ID: 21088608
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and safety of ketamine in the management of anxiety and anxiety spectrum disorders: a review of the literature.
    Banov MD; Young JR; Dunn T; Szabo ST
    CNS Spectr; 2020 Jun; 25(3):331-342. PubMed ID: 31339086
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetic evaluation of pregabalin for the treatment of generalized anxiety disorder.
    Buoli M; Caldiroli A; Serati M
    Expert Opin Drug Metab Toxicol; 2017 Mar; 13(3):351-359. PubMed ID: 28075650
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 18.